These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 515801)

  • 1. Dipyridamole in the treatment of dengue haemorrhagic fever.
    Kho LK; Wulur H; Himawan T
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):385-8. PubMed ID: 515801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin and antiplasmin on platelet level in dengue haemorrhagic fever.
    Uttayopas C
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):380-2. PubMed ID: 3433167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue fever outbreak in Karachi 2006--a study of profile and outcome of children under 15 years of age.
    Ahmed S; Arif F; Yahya Y; Rehman A; Abbas K; Ashraf S; Akram DS
    J Pak Med Assoc; 2008 Jan; 58(1):4-8. PubMed ID: 18297966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic derangement in dengue haemorrhagic fever.
    Isarangkura PB; Pongpanich B; Pintadit P; Phanichyakarn P; Valyasevi A
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):331-9. PubMed ID: 3433165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombosis prevention and treatment in pediatrics].
    Weissbach G
    Z Gesamte Inn Med; 1979 Jan; 34(1):35-40. PubMed ID: 373278
    [No Abstract]   [Full Text] [Related]  

  • 6. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection.
    Kittigul L; Pitakarnjanakul P; Sujirarat D; Siripanichgon K
    J Clin Virol; 2007 Jun; 39(2):76-81. PubMed ID: 17507286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of heparin and dipyridamol (persantin) in the treatment of various coagulation disorders in infants].
    Prişcu R; Maiorescu M; Manolescu E; Anca I; Coeugniet E
    Rev Pediatr Obstet Ginecol Pediatr; 1974; 23(4):339-45. PubMed ID: 4219648
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disseminated intravascular coagulation. II. Therapeutic problems].
    Boccaccio P; Ghio R; Ratti M; Casciaro S; Rattenni S; Sergnese G
    Minerva Med; 1982 Feb; 73(7):309-20. PubMed ID: 6173819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M
    Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
    El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
    J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines.
    Carlos CC; Oishi K; Cinco MT; Mapua CA; Inoue S; Cruz DJ; Pancho MA; Tanig CZ; Matias RR; Morita K; Natividad FF; Igarashi A; Nagatake T
    Am J Trop Med Hyg; 2005 Aug; 73(2):435-40. PubMed ID: 16103617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras.
    De Rivera IL; Parham L; Murillo W; Moncada W; Vazquez S
    Am J Trop Med Hyg; 2008 Aug; 79(2):262-6. PubMed ID: 18689634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding manifestations of dengue haemorrhagic fever in Malaysia.
    George R; Duraisamy G
    Acta Trop; 1981 Mar; 38(1):71-8. PubMed ID: 6111919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between body size and severity of dengue hemorrhagic fever among children aged 0-14 years.
    Pichainarong N; Mongkalangoon N; Kalayanarooj S; Chaveepojnkamjorn W
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):283-8. PubMed ID: 17124987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against marked plasma leakage in dengue haemorrhagic fever by infusion of carbazochrome sodium sulfonate (AC-17).
    Funahara Y; Sumarmo ; Shirahata A; Harun SR; Setiabudy-Dharma R; Nathin MA; Karjomanggolo TW; Tamaela LA
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):356-61. PubMed ID: 2963380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dengue haemorrhagic fever in children: ten years of clinical experience].
    Méndez A; González G
    Biomedica; 2003 Jun; 23(2):180-93. PubMed ID: 12872557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and experimental aspects of antithrombotic treatment in children].
    Prişcu R; Maiorescu M; Manolescu E; Anca I; Coeugniet E; Petrescu C; Brezina A
    Rev Pediatr Obstet Ginecol Pediatr; 1975; 24(4):359-70. PubMed ID: 814603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.